2,887
Participants
Start Date
December 1, 2017
Primary Completion Date
July 31, 2020
Study Completion Date
July 31, 2022
HIV-1 RNA testing
During the intervention period, a blood sample will be obtained and tested for AHI using point-of-care Xpert® HIV Qual assay (Cepheid, Sunnyvale, California, USA). Individuals who test positive will undergo rapid tests to differentiate acute from prevalent HIV infection. Newly diagnosed individuals will be offered immediate ART and assisted partner notification with the HIV-1 RNA testing intervention delivered to partners following the same approach.
KEMRI Mtwapa, Kilifi
University of Washington
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of Oxford
OTHER